SCHEMBL13555658

SCHEMBL13555658

CN[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)NC(C)=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GNPAT O15228 1/20 0.48
▸ BMP1 P13497 3/20 0.39
▸ MME P08473 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ THRB P10828 1/20 0.32
▸ ALOX15 P16050 1/20 0.32
▸ NFKB1 P19838 1/20 0.32
▸ PTGS2 P35354 1/20 0.32
▸ THPO P40225 1/20 0.32
▸ RECQL P46063 1/20 0.32
▸ BLM P54132 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ MMP8 P22894 1/20 0.32
▸ CA2 P00918 1/20 0.32
▸ CA4 P22748 1/20 0.32
▸ ADRA1A P35348 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ ENPEP Q07075 5/20 0.32
▸ SIRT5 Q9NXA8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27267745 0.85 GNPAT (0.46) GNPATBMP1MMEMMP8CA2
SCHEMBL13377669 0.85 GNPAT (0.46) GNPATBMP1MMEMMP8CA2
SCHEMBL19263682 0.83 GNPAT (0.51) GNPATBMP1MMECA2CA4
SCHEMBL27267642 0.83 GNPAT (0.44) GNPATBMP1MMEKDM4EMAPT
SCHEMBL22316503 0.83 GNPAT (0.51) GNPATBMP1MMECA2CA4
SCHEMBL16248346 0.83 GNPAT (0.46) GNPATBMP1MMEENPEP
SCHEMBL11956575 0.81 GNPAT (0.49) GNPATMMECA2CA4ENPEP
SCHEMBL13555664 0.80 GNPAT (0.43) GNPATBMP1MMEMAPTMMP8
SCHEMBL13555660 0.80 GNPAT (0.43) GNPATBMP1MMEMMP8ADRA1A
SCHEMBL13402943 0.80 GNPAT (0.45) GNPATBMP1MMEENPEPSIRT5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120270811-A1 CONFORMATIONS OF DIVERGENT PEPTIDES WITH MINERAL BINDING AFFINITY KAOHSIUNG MEDICAL UNIVERSITY (TW) 2012-10-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120270811-A1 CONFORMATIONS OF DIVERGENT PEPTIDES WITH MINERAL BINDING AFFINITY SDF4, CALCB, CALCA GNPAT 2505/4885BMP1 14/4885MME 1055/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback